BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 27340918)

  • 1. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal trends in atrial fibrillation episodes and physical activity collected daily with a remote monitoring system for cardiac implantable electronic devices.
    Censi F; Calcagnini G; Mattei E; Calò L; Curnis A; D'Onofrio A; Vaccari D; Zanotto G; Morichelli L; Rovai N; Gargaro A; Ricci RP
    Int J Cardiol; 2017 May; 234():48-52. PubMed ID: 28258846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through monte carlo simulations.
    Ricci RP; Morichelli L; Gargaro A; Laudadio MT; Santini M
    J Cardiovasc Electrophysiol; 2009 Nov; 20(11):1244-51. PubMed ID: 19602024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
    Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
    Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease management: atrial fibrillation and home monitoring.
    Ricci RP
    Europace; 2013 Jun; 15 Suppl 1():i35-i39. PubMed ID: 23737228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
    Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
    Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of atrial high-rate episodes on the risk of future stroke.
    Nakano M; Kondo Y; Nakano M; Kajiyama T; Hayashi T; Ito R; Takahira H; Kobayashi Y
    J Cardiol; 2019 Aug; 74(2):144-149. PubMed ID: 30728105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Ziegler PD; Rogers JD; Ferreira SW; Nichols AJ; Richards M; Koehler JL; Sarkar S
    Int J Cardiol; 2017 Oct; 244():175-179. PubMed ID: 28624331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
    Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
    Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.
    Martin DT; Bersohn MM; Waldo AL; Wathen MS; Choucair WK; Lip GY; Ip J; Holcomb R; Akar JG; Halperin JL;
    Eur Heart J; 2015 Jul; 36(26):1660-8. PubMed ID: 25908774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.
    Solari D; Bertero E; Miceli R; Brunelli C; Ameri P; Canepa M
    Int J Cardiol; 2017 Jun; 236():262-269. PubMed ID: 28143653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of remote monitoring of cardiac implantable electronic devices after stroke or transient ischemic attack.
    De Simone V; Zanotto G; Guarise P; Venturato A; Cassinadri E; Bassi M; Bozzolin M; Tondelli S; Giacopelli D; Morando G
    J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):551-556. PubMed ID: 31157660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
    Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
    Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
    Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
    Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
    Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
    Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices.
    Lorenzoni G; Folino F; Soriani N; Iliceto S; Gregori D
    J Eval Clin Pract; 2014 Oct; 20(5):570-7. PubMed ID: 24766368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.